Cecile Courbon

Dr. Cecile Courbon

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Medicina
Verified
Journal Article
Open access
PDF file
AKAxel Kerroum
Axel Kerroum
LRLorenzo Rosner
Lorenzo Rosner
ESEmmanuelle Scala
Emmanuelle Scala
MKMatthias Kirsch
Matthias Kirsch
PTPiergiorgio Tozzi
Piergiorgio Tozzi
VRValentina Rancati
Valentina Rancati
Background and Objectives: Dexmedetomidine, an alpha-2 agonist, is used as an adjunct to anesthesia in enhanced recovery after surgery (ERAS) programs. One of its advantages is the opioid-sparing effect which can facilitate early extubation and recovery. When the ERAS cardiac society was set in 2017, our facility was already using the ERAS program, in which the “fast-track Anesthesia” was facilitated by the intraoperative infusion of dexmedetomidine. Our objective is to share our experience and investigate the potential impact of intraoperative dexmedetomidine use as a part of the ERAS program on patient outcomes in elective cardiac surgery. Materials and Methods: An observational retrospective cohort study was conducted at a university hospital in Switzerland. The patients who underwent elective cardiac surgery with cardiopulmonary bypass between 1 June 2017 and 31 August 2018 were included in this analysis (n = 327). Regardless of the surgery type, all the patients received a standardized fast-track anesthesia protocol inclusive of dexmedetomidine infusion, reduced opioid dose, and parasternal nerve block. The primary outcome was the postoperative time when the criteria for extubation were met. Three groups were identified: group 0—(extubated in the operating room), group < 6 (extubated in less than 6 h), and group > 6 (extubated in >6 h). The secondary outcomes were adverse events, length of stay in ICU and in hospital, and total hospitalization costs. Results: Dexmedetomidine was well-tolerated, with no significant adverse events reported. Early extubation was performed in 187 patients (57%). Group 3 had a significantly longer length of stay in the ICU (median: 70 h vs. 25 h) and in hospital (17 vs. 12 days), and consequently higher total hospitalization costs (CHF 62,551 vs. 38,433) compared to the net data from the other two groups (p < 0.0001). Conclusions: Our findings suggest that dexmedetomidine can be safely used as part of the opioid-sparing anesthesia protocol in patients undergoing elective cardiac surgery with cardiopulmonary bypass with the potential to facilitate early extubation, shorter ICU and hospital stays, and reduced hospitalization costs.

1 April 2023 in OTO Open
Verified
Journal Article
Open access
CCCecile Courbon
Cecile Courbon
Objective: Spontaneous ventilation under intravenous anesthesia allows the surgeon to work without interruption or obstruction of the operating field during suspension microlaryngoscopy (SML). High‐flow nasal oxygen therapy (HFNO) is increasingly used in anesthesia. We hypothesized that its use during SML would increase patient safety even in situations where the airway is compromised by tumor or stenosis.Study Design: Retrospective observational study.Setting: University Hospital of Lausanne, Switzerland.Methods: Adults patients who were scheduled for elective microlaryngeal surgery and managed with HFNO in spontaneous ventilation under general anesthesia between October 2020 and December 2021.Results: Twenty‐seven patients for a total of 32 surgical procedures were performed under HFNO with spontaneous ventilation. Seventy‐five percent of the patients had respiratory symptoms. Twelve patients (42.9%) were planned for the treatment of subglottic or tracheal stenosis and 5 patients were managed for vocal cord cancer (18.5%). Out of 32 surgeries, 4 cases of saturation < 92% occurred, 3 of them during the decrease of the fraction of inspired oxygen to 30% for the use of the laser. In 3 cases, the patients were intubated to correct the hypoxemia.Conclusion: Spontaneous respiration using intravenous anesthesia and high‐flow nasal oxygen is a modern technique that increases patient safety while allowing the surgeon to work without interruption or imputation of the operative field during SML. This approach is particularly promising for the management of airways compromised by tumors or laryngotracheal stenosis.

1 July 2014 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
CCCecile Courbon
Cecile Courbon
PBP. Bize
P. Bize
MRM. Chollet Rivier
M. Chollet Rivier
ADA. Denys
A. Denys

31 May 2024 in Journal of PeriAnesthesia Nursing
Verified
Journal Article
Open access
ZWZoé Wahl
Zoé Wahl
CCCecile Courbon
Cecile Courbon
JMJohn Rey B. Macindo
John Rey B. Macindo
GTGian Carlo S. Torres
Gian Carlo S. Torres
CLClaudia Lecoultre
Claudia Lecoultre
Preoperative evaluation of elective surgery patients traditionally focuses on somatic and organizational aspects of the situation. Patient feelings of readiness, called preoperative readiness (PR), impacts postoperative outcomes, and yet is rarely evaluated. The Preoperative Assessment Tool (PART) is a validated and reliable 15-item questionnaire available in Filipino and English. A reliable tool is essential for evaluating PR within the Swiss health context to offer optimized and comprehensive perioperative care. The aim of this study was to both translate into French and adapt culturally the Preoperative Assessment Tool for Switzerland's francophone population, and to explore patient PR in the preoperative consultation within a Swiss tertiary hospital. A mixed design with methodologic phases and descriptive study. A mixed design in two phases with a methodologic phase with (1) translation and (2) cultural adaptation for Romandie of the PART, following Wild's 10 steps methodology (n = 11) and (3) a cross-sectional exploratory descriptive study with pilot testing of the translated version in a general elective preoperative consultation in a tertiary hospital in Romandie (N = 88). Translation and cultural adaptations are well accepted and understood by the participants (n = 9/11), modifications are accepted by the authors and deemed adequate by the participants (n = 11/11). Time of completion is short (m = 69.06 seconds) and adapted to clinical context. The translated version has a Cronbach (α = 0.85) comparable to the original validated scale (α = 0.86). The translation and cultural adaptation for Switzerland of the PART was achieved, and PR was explored. Further psychometric testing of the PART-FrenCH must be conducted to assess fully the tool before its use in a clinical setting. Including PR in preoperative evaluations could enhance patient-centered approaches and lead to improvement in the quality of care.

24 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MNMaria Vittoria Nanni
Maria Vittoria Nanni
CCCecile Courbon
Cecile Courbon
CLCarlotta Lambertini
Carlotta Lambertini
AWAlexander Felix Wyss
Alexander Felix Wyss
FLFlorian Lanz
Florian Lanz
ABalessandra bergadano
alessandra bergadano
Remifentanil is routinely administered in human neurosurgery whilst its use in non-human primates is not described. Here we described a new remifentanil-propofol total intravenous anesthesia (TIVA) for macaque neurosurgery and we compared it retrospectively to fentanyl-propofol anesthesia. Twelve anesthesias were performed (F=6; R=6). After premedication, anesthesia was induced with 3 mcg/kg fentanyl (F) or 3 mcg/kg remifentanil (R) intravenously (IV) and maintained through propofol and fentanyl [0.17 ± 0.01 mcg/kg/min after induction and 0.13 ± 0.01 mcg/kg/min during maintenance] or remifentanil [0.1 ± 0.02 mcg/kg/min after induction and 0.16 ± 0.05 mcg/kg/min during maintenance] constant-rate-infusion (CRI), respectively. Tracheal intubation in R was characterized by apnea, absence of laryngeal reaction, and cough compared to F. The mean propofol rate administered in F [0.3 ± 0.1 at start to 0.2± 0.1 mg/kg/min for maintenance] was significantly higher than in R [0.17 ± 0.1 at start to 0.16 ± 0.01 mg/kg/min for maintenance].The cardiovascular and respiratory parameters did not differ significantly between the two groups. Extubation time was shorter in R compared to F [8 (6– 10) and 18 (14– 22) minutes respectively]. Finally, the new remifentanil-propofol TIVA proved to be a beneficial refinement for macaque neurosurgery, providing smoother intubation, cardiovascular stability, lower propofol requirements and faster recovery.